Search Publications


per page

Found 262 matches. Displaying 1-10 Toggle highlighting of searched terms

[ 1-10 | Next ]

1. Czarnowicki T, Esaki H, Gonzalez J, Malajian D, Shemer A, Noda S, Talasila S, Berry A, Gray J, Becker L, Estrada Y, Xu H, Zheng XZ, Suarez-Farinas M, Krueger JG, Paller AS, Guttman-Yassky E   Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA) 1 T(H)2/T(H)1 cell imbalance, whereas adults acquire CLA1(+) T(H)22/T(C)22 cell subsets   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2015 OCT; 136(4):941-+ Full Text | PMID/PMCID

2. Ewald DA, Malajian D, Krueger JG, Workman CT, Wang TJ, Tian SY, Litman T, Guttman-Yassky E, Suarez-Farinas M   Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways   BMC MEDICAL GENOMICS 2015 OCT 12; 8(?):? Article 60 Full Text | PMID/PMCID

3. Papp K, Thaci D, Reich K, Riedl E, Langley RG, Krueger JG, Gottlieb AB, Nakagawa H, Bowman EP, Mehta A, Li Q, Zhou Y, Shames R   Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial   BRITISH JOURNAL OF DERMATOLOGY 2015 OCT; 173(4):930-939 Full Text | PMID/PMCID

4. Humme D, Haider A, Mobs M, Mitsui H, Suarez-Farinas M, Ohmatsu H, Geilen CI, Eberle J, Krueger JG, Beyer M, Hummel M, Anagnostopoulos I, Sterry W, Assaf C   Aurora Kinase A Is Upregulated in Cutaneous T-Cell Lymphoma and Represents a Potential Therapeutic Target   JOURNAL OF INVESTIGATIVE DERMATOLOGY 2015 SEP; 135(9):2292-2300 Full Text | PMID/PMCID

5. Papp K, Pariser D, Catlin M, Wierz G, Ball G, Akinlade B, Zeiher B, Krueger JG   A phase 2a randomized, double-blind, placebo-controlled, sequential dose-escalation study to evaluate the efficacy and safety of ASP015K, a novel Janus kinase inhibitor, in patients with moderate-to-severe psoriasis   BRITISH JOURNAL OF DERMATOLOGY 2015 SEP; 173(3):767-776 Full Text | PMID/PMCID

6. Gottlieb AB, Krueger JG, Lundblad MS, Gothberg M, Skolnick BE   First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti-IL-20 Monoclonal Antibody in Patients with Psoriasis   PLOS ONE 2015 AUG 7; 10(8):? Article e0134703 Full Text | PMID/PMCID

7. Goldminz AM, Suarez-Farinas M, Wang AC, Dumont N, Krueger JG, Gottlieb AB   CCL20 and IL22 Messenger RNA Expression After Adalimumab vs Methotrexate Treatment of Psoriasis A Randomized Clinical Trial   JAMA DERMATOLOGY 2015 AUG; 151(8):837-846 Full Text | PMID/PMCID

8. Vukmanovic-Stejic M, Sandhu D, Seidel JA, Patel N, Sobande TO, Agius E, Jackson SE, Fuentes-Duculan J, Suarez-Farinas M, Mabbott NA, Lacy KE, Ogg G, Nestle FO, Krueger JG, Rustin MHA, Akbar AN   The Characterization of Varicella Zoster Virus-Specific T Cells in Skin and Blood during Aging   JOURNAL OF INVESTIGATIVE DERMATOLOGY 2015 JUL; 135(7):1752-1762 Full Text | PMID/PMCID

9. Czarnowicki T, Malajian D, Shemer A, Fuentes-Duculan J, Gonzalez J, Suarez-Farinas M, Krueger JG, Guttman-Yassky E   Skin-homing and systemic T-cell subsets show higher activation in atopic dermatitis versus psoriasis   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2015 JUL; 136(1):208-211 Full Text | PMID/PMCID

10. Krueger JG, Ferris LK, Menter A, Wagner F, White A, Visvanathan S, Lalovic B, Aslanyan S, Wang EEL, Hall D, Solinger A, Padula S, Scholl P   Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2015 JUL; 136(1):116-U231 Full Text | PMID/PMCID

[ 1-10 | Next ]